カテゴリ： GlobalData, アメリカ, 企業調査

PerkinElmer Inc (PKI)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：PerkinElmer Inc (PKI) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7085
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：94
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services to diagnostics, research, food, laboratory services, environmental, and industrial markets. The company’s major products include cytogenetics reagents, ELISA Kits, tissue biomarker reagents, atomic spectroscopy instruments, chromatography instruments, molecular spectroscopy, newborn screening instruments and thermal analysis instruments, among others. It offers reagents, instruments, assay platforms and software to hospitals, clinicians, medical labs and medical research professionals. PerkinElmer also offers cord blood and tissue banking, laboratory and research services, among others. Its products are used in various applications, including atomic spectroscopy, cell imaging and analysis, chromatography, DNA/RNA isolation, analysis and detection, in vivo imaging, molecular spectroscopy, protein analysis and detection, and tissue imaging, among others. The company operates in Asia-Pacific, Europe and North America, among others. PerkinElmer is headquartered in Waltham, Massachusetts, US.

PerkinElmer Inc (PKI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
PerkinElmer Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
PerkinElmer Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 8
PerkinElmer Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
PerkinElmer Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 10
PerkinElmer Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
PerkinElmer Inc, Medical Equipment, Deal Details 13
Partnerships 13
Euroimmun Enters into Licensing Agreement with Iron Horse Diagnostics 13
Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology 14
PerkinElmer Expands Licensing Agreement With Tibco Software 15
PerkinElmer Enters Into Licensing Agreement With Tibco Software For Tibco Spotfire 16
PerkinElmer Enters Into Licensing Agreement With GenMark Diagnostics For Microfluidics Patent Portfolio 17
Agena Bioscience Enters into Agreement with PerkinElmer 18
Enzyvant Enters into Collaboration Agreement PerkinElmer 19
PerkinElmer Enters into Agreement with Helix OpCo 20
Mobidiag Expand Agreement with Wallac 21
10X Genomics Enters into Agreement with PerkinElmer 22
Euroimmun Enters into Agreement with Angsana Molecular & Diagnostics 23
Reproductive Health Science Enters into Distribution Agreement with Tani Medikal for EmbryoCellect 24
OncoSec Medical Enters into Research Agreement with University of California and PerkinElmer 25
Sofie Biosciences and PerkinElmer Extends Partnership 26
PerkinElmer Enters into Distribution Agreement with Sebia 27
Good Start Genetics Enters Into Agreement With PerkinElmer To Provide GoodStart Select Carrier Screening Tests 28
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 29
ViaCord Enters Into Agreement With Center for International Blood and Marrow Transplant Research For Stem Cell Therapy Research 30
PerkinElmer Enters Into Agreement With National Center for Drug Screening 31
PerkinElmer Enters Into Co-Marketing Agreement With Verinata Health For Verifi Test 32
Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 33
Integromics Enters Into Co-Development Agreement With Galician Foundation Of Genomic Medicine 34
Equity Offering 35
Reproductive Health Science Raises USD1.12 Million in Private Placement of Shares 35
PerkinElmer Plans to Spin Out Diagnostics Business 36
Reproductive Health Science Raises USD1 Million in Private Placement of Shares 37
Debt Offering 38
PerkinElmer Raises USD370.1 Million in Public Offering of 0.6% Notes Due 2021 38
PerkinElmer Raises EUR553 Million in Public Offering of 1.875% Notes Due 2026 39
PerkinElmer Raises USD552.3 Million in Public Offering of 1.875% Senior Notes Due 2026 40
Asset Transactions 42
Varex Imaging Acquires Medical Imaging Business of PerkinElmer 42
Acquisition 43
PerkinElmer Acquires Euroimmun for USD1.34 Billion 43
PerkinElmer Acquires Tulip Diagnostics 45
PerkinElmer Acquires Bioo Scientific for USD63.5 Million 46
PerkinElmer Acquires Vanadis Diagnostics 47
AO Energy Completes Acquisition of Reproductive Health Science 48
PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech 49
PerkinElmer Inc – Key Competitors 50
PerkinElmer Inc – Key Employees 51
PerkinElmer Inc – Locations And Subsidiaries 52
Head Office 52
Other Locations & Subsidiaries 52
Joint Venture 57
Recent Developments 58
Strategy And Business Planning 58
Sep 21, 2017: State Key Laboratory of Biochemical Engineering and PerkinElmer Open Joint Translational Medical Engineering Demonstration Laboratory in Beijing 58
Financial Announcements 59
Aug 01, 2018: PerkinElmer Announces Financial Results for the Second Quarter of 2018 59
Apr 30, 2018: PerkinElmer Reports Financial Results for the First Quarter of 2018 60
Jan 25, 2018: PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2017 61
Nov 02, 2017: PerkinElmer Announces Financial Results for the Third Quarter of 2017 63
Aug 03, 2017: PerkinElmer Announces Financial Results for the Second Quarter of 2017 64
May 04, 2017: PerkinElmer Announces Financial Results for the First Quarter of 2017 65
Feb 02, 2017: PerkinElmer Announces Financial Results for Fourth Quarter and Full Year 2016 66
Corporate Communications 68
Apr 10, 2018: PerkinElmer Names James Mock as Chief Financial Officer 68
Oct 30, 2017: PerkinElmer Elects Pascale Witz to its Board of Directors 69
Sep 15, 2017: PerkinElmer Announces Future Retirement of Andy Wilson, Chief Financial Officer 70
Product News 71
Oct 02, 2018: PerkinElmer launches asset Genius System for remote laboratory monitoring 71
Jul 17, 2018: PerkinElmer to Highlight Comprehensive Diagnostics Technologies at AACC 2018 72
May 31, 2018: PerkinElmer Launches NEXTflex Unique Dual Index Barcodes for Increased Confidence in Sequencing Data 74
May 31, 2018: PerkinElmer to Highlight Mass Spectrometry and Chromatography Solutions at 2018 ASMS Conference 75
May 15, 2018: PerkinElmer Signals Screening Software Streamlines Data Analysis, Increases Speed and Reliability of Drug Discovery 76
May 10, 2018: PerkinElmer to Showcase Informatics Technologies at 2018 Bio-IT World Conference Expo 77
Apr 06, 2018: PerkinElmer to Display Broad Range of Advanced Laboratory Technologies at Analytica 2018 79
Jan 29, 2018: PerkinElmer Launches CE-IVD Assay Kit to Screen Newborns Affected by Duchenne Muscular Dystrophy 82
Jan 22, 2018: PerkinElmer to Showcase Innovative Workflow Solutions at SLAS 2018 83
Apr 03, 2017: New Cloud-Based PerkinElmer Signals Notebook Helps Scientists Accelerate Drug Discovery Research 85
Mar 23, 2017: PerkinElmer to Display Portfolio of Cancer Research Technologies and Workflow Solutions at 2017 AACR Annual Meeting 86
Jan 26, 2017: PerkinElmer Launches Vectra Polaris Automated Quantitative Pathology Imaging System 88
Other Significant Developments 89
Apr 05, 2018: Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program 89
Feb 28, 2018: PerkinElmer Signals Translational Contributes to Pre-Clinical and Clinical Data Analysis at the Frederick National Laboratory for Cancer Research 90
Sep 14, 2017: PerkinElmer and in-Depth Genomics Team Up for Whole Genome Sequencing Diagnostic Program for Rare Diseases 91
Aug 03, 2017: PerkinElmer Launches Clinical Whole Genome Sequencing Services 92
Mar 08, 2017: HISTALIM is The First European Laboratory to Adopt the Vectra Polaris Automated Quantitative Pathology Imaging System Developed by PerkinElmer 93
Appendix 94
Methodology 94
About GlobalData 94
Contact Us 94
Disclaimer 94

List of Tables
PerkinElmer Inc, Medical Equipment, Key Facts, 2017 2
PerkinElmer Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
PerkinElmer Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
PerkinElmer Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 8
PerkinElmer Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
PerkinElmer Inc, Deals By Market, 2012 to YTD 2018 10
PerkinElmer Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Euroimmun Enters into Licensing Agreement with Iron Horse Diagnostics 13
Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology 14
PerkinElmer Expands Licensing Agreement With Tibco Software 15
PerkinElmer Enters Into Licensing Agreement With Tibco Software For Tibco Spotfire 16
PerkinElmer Enters Into Licensing Agreement With GenMark Diagnostics For Microfluidics Patent Portfolio 17
Agena Bioscience Enters into Agreement with PerkinElmer 18
Enzyvant Enters into Collaboration Agreement PerkinElmer 19
PerkinElmer Enters into Agreement with Helix OpCo 20
Mobidiag Expand Agreement with Wallac 21
10X Genomics Enters into Agreement with PerkinElmer 22
Euroimmun Enters into Agreement with Angsana Molecular & Diagnostics 23
Reproductive Health Science Enters into Distribution Agreement with Tani Medikal for EmbryoCellect 24
OncoSec Medical Enters into Research Agreement with University of California and PerkinElmer 25
Sofie Biosciences and PerkinElmer Extends Partnership 26
PerkinElmer Enters into Distribution Agreement with Sebia 27
Good Start Genetics Enters Into Agreement With PerkinElmer To Provide GoodStart Select Carrier Screening Tests 28
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 29
ViaCord Enters Into Agreement With Center for International Blood and Marrow Transplant Research For Stem Cell Therapy Research 30
PerkinElmer Enters Into Agreement With National Center for Drug Screening 31
PerkinElmer Enters Into Co-Marketing Agreement With Verinata Health For Verifi Test 32
Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 33
Integromics Enters Into Co-Development Agreement With Galician Foundation Of Genomic Medicine 34
Reproductive Health Science Raises USD1.12 Million in Private Placement of Shares 35
PerkinElmer Plans to Spin Out Diagnostics Business 36
Reproductive Health Science Raises USD1 Million in Private Placement of Shares 37
PerkinElmer Raises USD370.1 Million in Public Offering of 0.6% Notes Due 2021 38
PerkinElmer Raises EUR553 Million in Public Offering of 1.875% Notes Due 2026 39
PerkinElmer Raises USD552.3 Million in Public Offering of 1.875% Senior Notes Due 2026 40
Varex Imaging Acquires Medical Imaging Business of PerkinElmer 42
PerkinElmer Acquires Euroimmun for USD1.34 Billion 43
PerkinElmer Acquires Tulip Diagnostics 45
PerkinElmer Acquires Bioo Scientific for USD63.5 Million 46
PerkinElmer Acquires Vanadis Diagnostics 47
AO Energy Completes Acquisition of Reproductive Health Science 48
PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech 49
PerkinElmer Inc, Key Competitors 50
PerkinElmer Inc, Key Employees 51
PerkinElmer Inc, Other Locations 52
PerkinElmer Inc, Subsidiaries 53
PerkinElmer Inc, Joint Venture 57

List of Figures
PerkinElmer Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
PerkinElmer Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
PerkinElmer Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
PerkinElmer Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
PerkinElmer Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
PerkinElmer Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 8
PerkinElmer Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
PerkinElmer Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 10

★海外企業調査レポート[PerkinElmer Inc (PKI)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Xylem Inc (XYL)：企業の財務・戦略的SWOT分析
    Xylem Inc (XYL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Vodacom Group Limited：企業の戦略・SWOT・財務情報
    Vodacom Group Limited - Strategy, SWOT and Corporate Finance Report Summary Vodacom Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Desktop Genetics Ltd-医療機器分野：企業M&A・提携分析
    Summary Desktop Genetics Ltd (DeskGen) is a provider of genome editing solutions. The company offers software solutions for the design, synthesis and assembly of DNA. It offers deskgen, which is a software system that helps scientists to organize, optimize, and automate their research. DeskGen’s CRI …
  • AdvantEdge Healthcare Solutions Inc：医療機器：M&Aディール及び事業提携情報
    Summary AdvantEdge Healthcare Solutions Inc (AdvantEdge) is a healthcare service provider that offers medical billing, coding and revenue cycle management solutions. The center’s solutions include medical billing, coding, reporting, dashboards and business intelligence, consulting and practice manag …
  • First Solar Inc (FSLR)：電力：M&Aディール及び事業提携情報
    Summary First Solar Inc (First Solar) is a provider of comprehensive photovoltaic (PV) solar systems. It designs, manufactures, and sells PV solar modules. The company produces solar systems using cadmium telluride technology. First Solar also develops, designs, constructs, and sells PV solar power …
  • The Jean Coutu Group (PJC) Inc.：企業の戦略・SWOT・財務分析
    The Jean Coutu Group (PJC) Inc. - Strategy, SWOT and Corporate Finance Report Summary The Jean Coutu Group (PJC) Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • IMI plc：企業の戦略・SWOT・財務分析
    IMI plc - Strategy, SWOT and Corporate Finance Report Summary IMI plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Ferranti Computer Systems N.V.：戦略・SWOT・企業財務分析
    Ferranti Computer Systems N.V. - Strategy, SWOT and Corporate Finance Report Summary Ferranti Computer Systems N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Egalet Corp (EGLT)：医療機器：M&Aディール及び事業提携情報
    Summary Egalet Corp (Egalet) is a specialty pharmaceutical company that develops, manufactures and commercializes novel treatments for pain and other conditions. Its product portfolio includes OXAYDO (oxycodone HCl, USP) tablets CII for the management of acute and chronic moderate to severe pain; SP …
  • Guidewire Software, Inc. (GWRE)：企業の財務・戦略的SWOT分析
    Guidewire Software, Inc. (GWRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Dairygold Co-operative Society Ltd：企業の戦略的SWOT分析
    Dairygold Co-operative Society Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • GWA Group Limited (GWA)：企業の財務・戦略的SWOT分析
    GWA Group Limited (GWA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Masraf Al Rayan (Q.S.C.)：企業の戦略・SWOT・財務情報
    Masraf Al Rayan (Q.S.C.) - Strategy, SWOT and Corporate Finance Report Summary Masraf Al Rayan (Q.S.C.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • FLIR Systems Inc：企業の戦略・SWOT・財務情報
    FLIR Systems Inc - Strategy, SWOT and Corporate Finance Report Summary FLIR Systems Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Network Rail Limited：企業の戦略・SWOT・財務情報
    Network Rail Limited - Strategy, SWOT and Corporate Finance Report Summary Network Rail Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Saskatchewan Power Corp：企業の戦略的SWOT分析
    Saskatchewan Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Ensco Plc (ESV)：石油・ガス：M&Aディール及び事業提携情報
    Summary Ensco Plc (Ensco) is a provider of offshore drilling services to the global oil and gas industry. The company owns and operates fleet of drillships, semisubmersibles, moored semisubmersibles, premium jackups and deepwater managed units. It also provides drilling management services to custom …
  • AzurRx BioPharma Inc (AZRX)：企業の財務・戦略的SWOT分析
    AzurRx BioPharma Inc (AZRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Colabor Group Inc (GCL)：企業の財務・戦略的SWOT分析
    Colabor Group Inc (GCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Otter Tail Corp (OTTR)：企業の財務・戦略的SWOT分析
    Otter Tail Corp (OTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆